Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

University of Toronto

$17,500.00

An Investigation into Arresting the Support of Cancer Associated Fibroblasts on Cancer Metastasis

EF 2018-19

Résumé
Head and neck squamous cell carcinoma (HNSCC) is one of the most common types of cancers, with a high relapse rate and poor survival. Its growth and spread is heavily supported by cancer-associated fibroblasts (CAFs), which when activated, provide tumour cells with a continual stream of nutrients and structural resources. Previous work has shown the importance of CAFs to tumour invasive potential and so the goal of my project is to better understand CAF biology and find ways of inhibiting its activity to reduce the rate of cancer metastasis. There are two main components of my project. The first is to make sense of CAF diversity by using machine-learning techniques to categorize CAFs into functional subgroups. I will then analyse the gene expression and methylation profiles of each category to determine 1) from what cells those CAFs were derived, 2) how they became activated, and 3) why they have remained activated in the presence of cancer cells. This work will improve our understanding of CAF lineages and find potential mechanisms by which to prevent CAF formation. The second component is to inhibit CAF activity to reduce HNSCC metastasis. To do this, I will screen a library of small molecule inhibitors for compounds capable of inactivating CAFs. The inhibitors’ performance will be assessed via three functional tests: the ability to 1) limit CAF proliferation and change its shape, 2) reduce CAFs’ contractibility of collagen, and 3) decrease cancer cell invasion when exposed to treated CAFs. These experiments together will serve as the first step in developing a drug capable of controlling cancer metastasis. Overall, my project will not only further our understanding of tumour biology but also has the potential to improve HNSCC prognosis for all patients.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
406302
Name
Jin Jingshu (Helen)
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
An Investigation into Arresting the Support of Cancer Associated Fibroblasts on Cancer Metastasis
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Cancer; Cancer-Associated Fibroblasts (Cafs); Cellular Lineage; Gene Expression; Head And Neck Squamous Cell Carcinoma; Inactivation; Inhibition; Metastasis; Small Molecule Inhibitors; Subgrouping
Abstract
Head and neck squamous cell carcinoma (HNSCC) is one of the most common types of cancers, with a high relapse rate and poor survival. Its growth and spread is heavily supported by cancer-associated fibroblasts (CAFs), which when activated, provide tumour cells with a continual stream of nutrients and structural resources. Previous work has shown the importance of CAFs to tumour invasive potential and so the goal of my project is to better understand CAF biology and find ways of inhibiting its activity to reduce the rate of cancer metastasis. There are two main components of my project. The first is to make sense of CAF diversity by using machine-learning techniques to categorize CAFs into functional subgroups. I will then analyse the gene expression and methylation profiles of each category to determine 1) from what cells those CAFs were derived, 2) how they became activated, and 3) why they have remained activated in the presence of cancer cells. This work will improve our understanding of CAF lineages and find potential mechanisms by which to prevent CAF formation. The second component is to inhibit CAF activity to reduce HNSCC metastasis. To do this, I will screen a library of small molecule inhibitors for compounds capable of inactivating CAFs. The inhibitors’ performance will be assessed via three functional tests: the ability to 1) limit CAF proliferation and change its shape, 2) reduce CAFs’ contractibility of collagen, and 3) decrease cancer cell invasion when exposed to treated CAFs. These experiments together will serve as the first step in developing a drug capable of controlling cancer metastasis. Overall, my project will not only further our understanding of tumour biology but also has the potential to improve HNSCC prognosis for all patients.
Competitiondate
201812
Approvedterm2
1 yr 0 mth
Pinamesdelim
Jin, Jingshu (Helen)
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~